Azincourt Energy Corp. announced that permits have been received for ongoing exploration activities at the East Preston uranium project in the Athabasca Basin, Saskatchewan, Canada. The Company has received work authorization and permits from the Government of Saskatchewan to allow diamond drilling and limited ground geophysics through to the summer of 2026.

This effectively provides access to the ground for the next three winter field seasons. Azincourt Energy recognizes that the granting of these permits does not negate the rights of the local communities for meaningful consultation as the project progresses. The company continues to be engaged in regular meetings with the Clearwater River Dene Nation and other rights holders to ensure that the concerns of the local communities are addressed regarding the East Preston project.

A more in-depth engagement process will also be commencing within the next month with the La Loche Metis Local #39. The company endeavors to keep local stakeholders apprised of ongoing plans, results, and priorities for the property. The involvement of the local communities is essential for continued advancement of the East Preston Project.

Azincourt looks forward to a continued close working relationship with CRDN and other rights holders to ensure that any potential impacts and concerns are addressed and that the communities can benefit from activities in the area through support of local business, employment opportunities, and sponsorship of select community programs and initiatives. Local businesses are engaged to provide services and supplies and members of the Clearwater River Dene Nation and surrounding communities have been directly employed on site or to provide support and services to keep the camp and programs running. Planning is underway for a winter 2024 drill program focusing on the alteration zone associated with the K- and H-Zones.

The exact size, scope, and budget of this program is still to be determined and will be communicated as decisions are finalized and confirmed.